These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. ACP Journal Club: some antimicrobials increased admissions and ED visits for hypoglycemia in older users of glipizide or glyburide. Eliakim-Raz N; Leibovici L Ann Intern Med; 2015 Feb; 162(4):JC13. PubMed ID: 25686188 [No Abstract] [Full Text] [Related]
3. Rapid hypoglycemia onset associated with antimicrobial use in patients with diabetes: A nationwide population-based case-crossover study. Wang YC; Chen YT; Kuo SC; Chen TL; Chang FY Eur J Intern Med; 2016 Oct; 34():e14-e15. PubMed ID: 27233429 [No Abstract] [Full Text] [Related]
4. Octreotide as antidote for sulfonylurea-induced hypoglycemia. Schier JG; Hirsch ON; Chu J Ann Emerg Med; 2001 Apr; 37(4):417-8. PubMed ID: 11275841 [No Abstract] [Full Text] [Related]
6. Inadvertent sulfonylurea overdosage and hypoglycemia in an elderly woman: failure of serum hypoglycemia screening. Earle KE; Rushakoff RJ; Goldfine ID Diabetes Technol Ther; 2003; 5(3):449-51. PubMed ID: 12828829 [TBL] [Abstract][Full Text] [Related]
7. The Ser1369Ala variant of ABCC8 and the risk for severe sulfonylurea-induced hypoglycemia in German patients with Type 2 diabetes. Holstein JD; Kovacs P; Patzer O; Stumvoll M; Holstein A Pharmacogenomics; 2012 Jan; 13(1):5-7; author reply 9-10. PubMed ID: 22176616 [No Abstract] [Full Text] [Related]
8. Comparison of octreotide and standard therapy versus standard therapy alone for the treatment of sulfonylurea-induced hypoglycemia. Francis M; Langhan T; Prosser J; Hoffman R Ann Emerg Med; 2008 Jun; 51(6):795-6; author reply 796-7. PubMed ID: 18489980 [No Abstract] [Full Text] [Related]
9. Octreotide treatment for sulfonylurea-induced hypoglycaemia. Crawford BA; Perera C Med J Aust; 2004 May; 180(10):540-1; author reply 541. PubMed ID: 15139835 [No Abstract] [Full Text] [Related]
10. Sulphonylurea-induced hypoglycaemia in institutionalized elderly in Hong Kong. So WY; Chan JC; Yeung VT; Chow CC; Ko GT; Li JK; Cockram CS Diabet Med; 2002 Nov; 19(11):966-8. PubMed ID: 12421437 [No Abstract] [Full Text] [Related]
11. Diagnosis and treatment of sulfonylurea-induced hyperinsulinemic hypoglycemia. Graudins A; Linden CH; Ferm RP Am J Emerg Med; 1997 Jan; 15(1):95-6. PubMed ID: 9002583 [No Abstract] [Full Text] [Related]
13. [Measures to meet the side effects of sulfonylurea (SU) in the treatment of type 2 diabetes]. Furukawa H; Ishida H Nihon Rinsho; 2002 Sep; 60 Suppl 9():357-61. PubMed ID: 12387018 [No Abstract] [Full Text] [Related]
14. Exorcising the specter of nighttime hypoglycemia. Scheiner G Diabetes Self Manag; 2012; 29(1):16, 18-20. PubMed ID: 22482132 [No Abstract] [Full Text] [Related]
15. Comment: "Quantitative insulin and C peptide levels among ED patients with sulfonylurea-induced hypoglycemia". Livshits Z; Hoffman RS Am J Emerg Med; 2011 Sep; 29(7):812-3. PubMed ID: 21872103 [No Abstract] [Full Text] [Related]
16. Sulphonylureas and hypoglycaemia. Ferner RE; Neil HA Br Med J (Clin Res Ed); 1988 Apr; 296(6627):949-50. PubMed ID: 3129103 [No Abstract] [Full Text] [Related]
18. [Persistent hyperinsulinemic hypoglycemia in newborn associated with glimepiride treatment at the beginning of pregnancy]. Balaguer Santamaría JA; Feliu Rovira A; Escribano Subias J; Salvadó Juncosa O; Sardá Auré P; Gussinyé Canadell M Rev Clin Esp; 2000 Jul; 200(7):399-400. PubMed ID: 10994361 [No Abstract] [Full Text] [Related]
19. Severe hypoglycaemia the "tip of the iceberg": an underestimated risk in both type 1 and type 2 diabetic patients. Halimi S Diabetes Metab; 2015 Apr; 41(2):105-6. PubMed ID: 25824635 [No Abstract] [Full Text] [Related]